These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis. Kean WF; Dwosh IL; Anastassiades TP; Ford PM; Kelly HG Arthritis Rheum; 1980 Feb; 23(2):158-64. PubMed ID: 7362666 [TBL] [Abstract][Full Text] [Related]
5. [Clinical experiences with d-penicillamine in rheumatoid arthritis (author's transl)]. Saxer M; Oeding A; Kaganas G; Vogt E Schweiz Rundsch Med Prax; 1977 Feb; 66(8):240-6. PubMed ID: 840828 [No Abstract] [Full Text] [Related]
6. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis]. Tausch G; Bröll H; Eberl R Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434 [No Abstract] [Full Text] [Related]
7. Reaction to D-penicillamine in rheumatoid arthritis. Day AT; Golding JR Br Med J; 1973 Sep; 3(5880):593. PubMed ID: 4726943 [No Abstract] [Full Text] [Related]
9. Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis. Shiokawa Y; Horiuchi Y; Honma M; Kageyama T; Okada T; Azuma T Arthritis Rheum; 1977; 20(8):1464-72. PubMed ID: 144507 [TBL] [Abstract][Full Text] [Related]
10. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW Ann Rheum Dis; 1975 Oct; 34(5):416-21. PubMed ID: 769707 [TBL] [Abstract][Full Text] [Related]
11. [Effects and adverse effects in D-penicillamine therapy]. Runge E; Tellkamp F Z Arztl Fortbild (Jena); 1977 Jul; 71(13):643-6. PubMed ID: 930141 [No Abstract] [Full Text] [Related]
12. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial. Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S Br Med J; 1976 May; 1(6017):1052-4. PubMed ID: 773500 [TBL] [Abstract][Full Text] [Related]
13. Controlled trial of D(-)penicillamine in severe rheumatoid arthritis. Lancet; 1973 Feb; 1(7798):275-80. PubMed ID: 4119168 [No Abstract] [Full Text] [Related]
14. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis. Davis P; Bleehen SS Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821 [No Abstract] [Full Text] [Related]
15. Management of proteinuria secondary to penicillamine therapy in rheumatoid arthritis. DeSilva RN; Eastmond CJ Clin Rheumatol; 1992 Jun; 11(2):216-9. PubMed ID: 1617896 [TBL] [Abstract][Full Text] [Related]
16. Reaction to D-penicillamine in rheumatoid arthritis. Shafar J; Hollanders D Br Med J; 1973 Aug; 3(5874):289. PubMed ID: 4723471 [No Abstract] [Full Text] [Related]
18. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly. Kean WF; Anastassiades TP; Dwosh IL; Ford PM; Kelly WG; Dok CM J Am Geriatr Soc; 1982 Feb; 30(2):94-100. PubMed ID: 6460054 [TBL] [Abstract][Full Text] [Related]
19. Penicillamine in rheumatoid disease: a long-term study. Day AT; Golding JR; Lee PN; Butterworth AD Br Med J; 1974 Feb; 1(5900):180-3. PubMed ID: 4590670 [TBL] [Abstract][Full Text] [Related]